B-Type Natriuretic Peptide-Guided Therapy and Length of Hospital Stay Post Left Ventricular Assist Device Implantation

Yaron Hellman, Adnan S. Malik, Hongbo Lin, Changyu Shen, I-Wen Wang, Thomas C. Wozniak, Zubair A. Hashmi, Arslan Shaukat, Jeanette Pickrell, Marco A. Caccamo, Irmina Gradus-Pizlo, Mohammed Hadi

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

B-type natriuretic peptide (BNP)-guided therapy during the early postoperative period following left ventricular assist device (LVAD) implantation has not been well described in the literature. We conducted a retrospective cohort study consisting of consecutive patients who underwent LVAD implantation at our institution during May 2009 to March 2013. The study was limited to patients receiving HeartMate II (Thoratec) or HVAD (HeartWare) LVADs. Patients with acute myocardial infarction were excluded. We compared between patients with multiple postoperative BNP tests (BNP-guided therapy) and earlier period patients who typically had only a baseline BNP measurement (non-BNP-guided therapy). A total of 85 patients underwent LVAD implantation during the study period. Eight patients were excluded (five acute myocardial infarction, three without BNP measurements). The only differences in the baseline characteristics of BNP versus non-BNP-guided therapy included age and female gender. The postoperative length of hospital stay (LOS) in the BNP-guided therapy group was 5 days shorter when compared with the non-BNP-guided therapy group. In multivariate analysis, BNP-guided therapy remained a significant predictor of reduced LOS. The use of repeated BNP measurements during the early postoperative period was associated with a significantly lower LOS post LVAD implantation.

Original languageEnglish (US)
Pages (from-to)156-160
Number of pages5
JournalASAIO Journal
Volume61
Issue number2
DOIs
StatePublished - Jul 21 2015

Fingerprint

Left ventricular assist devices
Heart-Assist Devices
Brain Natriuretic Peptide
Length of Stay
Natriuretic Peptides
Therapeutics
Group Psychotherapy
Postoperative Period
Myocardial Infarction
Cohort Studies
Multivariate Analysis
Retrospective Studies

Keywords

  • B-type natriuretic peptide
  • BNP-guided therapy
  • left ventricular assist device
  • length of hospital stay

ASJC Scopus subject areas

  • Biophysics
  • Biomaterials
  • Bioengineering
  • Biomedical Engineering
  • Medicine(all)

Cite this

B-Type Natriuretic Peptide-Guided Therapy and Length of Hospital Stay Post Left Ventricular Assist Device Implantation. / Hellman, Yaron; Malik, Adnan S.; Lin, Hongbo; Shen, Changyu; Wang, I-Wen; Wozniak, Thomas C.; Hashmi, Zubair A.; Shaukat, Arslan; Pickrell, Jeanette; Caccamo, Marco A.; Gradus-Pizlo, Irmina; Hadi, Mohammed.

In: ASAIO Journal, Vol. 61, No. 2, 21.07.2015, p. 156-160.

Research output: Contribution to journalArticle

Hellman, Y, Malik, AS, Lin, H, Shen, C, Wang, I-W, Wozniak, TC, Hashmi, ZA, Shaukat, A, Pickrell, J, Caccamo, MA, Gradus-Pizlo, I & Hadi, M 2015, 'B-Type Natriuretic Peptide-Guided Therapy and Length of Hospital Stay Post Left Ventricular Assist Device Implantation', ASAIO Journal, vol. 61, no. 2, pp. 156-160. https://doi.org/10.1097/MAT.0000000000000182
Hellman, Yaron ; Malik, Adnan S. ; Lin, Hongbo ; Shen, Changyu ; Wang, I-Wen ; Wozniak, Thomas C. ; Hashmi, Zubair A. ; Shaukat, Arslan ; Pickrell, Jeanette ; Caccamo, Marco A. ; Gradus-Pizlo, Irmina ; Hadi, Mohammed. / B-Type Natriuretic Peptide-Guided Therapy and Length of Hospital Stay Post Left Ventricular Assist Device Implantation. In: ASAIO Journal. 2015 ; Vol. 61, No. 2. pp. 156-160.
@article{3c5b446e2aa74c57955f3c9054106465,
title = "B-Type Natriuretic Peptide-Guided Therapy and Length of Hospital Stay Post Left Ventricular Assist Device Implantation",
abstract = "B-type natriuretic peptide (BNP)-guided therapy during the early postoperative period following left ventricular assist device (LVAD) implantation has not been well described in the literature. We conducted a retrospective cohort study consisting of consecutive patients who underwent LVAD implantation at our institution during May 2009 to March 2013. The study was limited to patients receiving HeartMate II (Thoratec) or HVAD (HeartWare) LVADs. Patients with acute myocardial infarction were excluded. We compared between patients with multiple postoperative BNP tests (BNP-guided therapy) and earlier period patients who typically had only a baseline BNP measurement (non-BNP-guided therapy). A total of 85 patients underwent LVAD implantation during the study period. Eight patients were excluded (five acute myocardial infarction, three without BNP measurements). The only differences in the baseline characteristics of BNP versus non-BNP-guided therapy included age and female gender. The postoperative length of hospital stay (LOS) in the BNP-guided therapy group was 5 days shorter when compared with the non-BNP-guided therapy group. In multivariate analysis, BNP-guided therapy remained a significant predictor of reduced LOS. The use of repeated BNP measurements during the early postoperative period was associated with a significantly lower LOS post LVAD implantation.",
keywords = "B-type natriuretic peptide, BNP-guided therapy, left ventricular assist device, length of hospital stay",
author = "Yaron Hellman and Malik, {Adnan S.} and Hongbo Lin and Changyu Shen and I-Wen Wang and Wozniak, {Thomas C.} and Hashmi, {Zubair A.} and Arslan Shaukat and Jeanette Pickrell and Caccamo, {Marco A.} and Irmina Gradus-Pizlo and Mohammed Hadi",
year = "2015",
month = "7",
day = "21",
doi = "10.1097/MAT.0000000000000182",
language = "English (US)",
volume = "61",
pages = "156--160",
journal = "ASAIO Journal",
issn = "1058-2916",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - B-Type Natriuretic Peptide-Guided Therapy and Length of Hospital Stay Post Left Ventricular Assist Device Implantation

AU - Hellman, Yaron

AU - Malik, Adnan S.

AU - Lin, Hongbo

AU - Shen, Changyu

AU - Wang, I-Wen

AU - Wozniak, Thomas C.

AU - Hashmi, Zubair A.

AU - Shaukat, Arslan

AU - Pickrell, Jeanette

AU - Caccamo, Marco A.

AU - Gradus-Pizlo, Irmina

AU - Hadi, Mohammed

PY - 2015/7/21

Y1 - 2015/7/21

N2 - B-type natriuretic peptide (BNP)-guided therapy during the early postoperative period following left ventricular assist device (LVAD) implantation has not been well described in the literature. We conducted a retrospective cohort study consisting of consecutive patients who underwent LVAD implantation at our institution during May 2009 to March 2013. The study was limited to patients receiving HeartMate II (Thoratec) or HVAD (HeartWare) LVADs. Patients with acute myocardial infarction were excluded. We compared between patients with multiple postoperative BNP tests (BNP-guided therapy) and earlier period patients who typically had only a baseline BNP measurement (non-BNP-guided therapy). A total of 85 patients underwent LVAD implantation during the study period. Eight patients were excluded (five acute myocardial infarction, three without BNP measurements). The only differences in the baseline characteristics of BNP versus non-BNP-guided therapy included age and female gender. The postoperative length of hospital stay (LOS) in the BNP-guided therapy group was 5 days shorter when compared with the non-BNP-guided therapy group. In multivariate analysis, BNP-guided therapy remained a significant predictor of reduced LOS. The use of repeated BNP measurements during the early postoperative period was associated with a significantly lower LOS post LVAD implantation.

AB - B-type natriuretic peptide (BNP)-guided therapy during the early postoperative period following left ventricular assist device (LVAD) implantation has not been well described in the literature. We conducted a retrospective cohort study consisting of consecutive patients who underwent LVAD implantation at our institution during May 2009 to March 2013. The study was limited to patients receiving HeartMate II (Thoratec) or HVAD (HeartWare) LVADs. Patients with acute myocardial infarction were excluded. We compared between patients with multiple postoperative BNP tests (BNP-guided therapy) and earlier period patients who typically had only a baseline BNP measurement (non-BNP-guided therapy). A total of 85 patients underwent LVAD implantation during the study period. Eight patients were excluded (five acute myocardial infarction, three without BNP measurements). The only differences in the baseline characteristics of BNP versus non-BNP-guided therapy included age and female gender. The postoperative length of hospital stay (LOS) in the BNP-guided therapy group was 5 days shorter when compared with the non-BNP-guided therapy group. In multivariate analysis, BNP-guided therapy remained a significant predictor of reduced LOS. The use of repeated BNP measurements during the early postoperative period was associated with a significantly lower LOS post LVAD implantation.

KW - B-type natriuretic peptide

KW - BNP-guided therapy

KW - left ventricular assist device

KW - length of hospital stay

UR - http://www.scopus.com/inward/record.url?scp=84937639725&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937639725&partnerID=8YFLogxK

U2 - 10.1097/MAT.0000000000000182

DO - 10.1097/MAT.0000000000000182

M3 - Article

C2 - 25485560

AN - SCOPUS:84937639725

VL - 61

SP - 156

EP - 160

JO - ASAIO Journal

JF - ASAIO Journal

SN - 1058-2916

IS - 2

ER -